Use of HMGB fragments as antiinflammatory agents

Details for Australian Patent Application No. 2003294488 (hide)

Owner Critical Therapeutics, Inc.

Inventors O'Keefe, Theresa L.; Newman, Walter

Agent Davies Collison Cave

Pub. Number AU-B-2003294488

PCT Number PCT/US2003/0375

PCT Pub. Number WO2004/046345

Priority 60/427,846 20.11.02 US; 60/427,841 20.11.02 US

Filing date 20 November 2003

Wipo publication date 15 June 2004

Acceptance publication date 24 May 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/427,846 20.11.02 US; 60/427,841 20.11.02 US

15 July 2004 Application Open to Public Inspection

  Published as AU-B-2003294488

24 May 2007 Application Accepted

  Published as AU-B-2003294488

20 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003294489-MONOUNSATURATED FATTY ACIDS AND PERHYDROCYCLOPENTANOPHENANTHRENE NUCLEUS COMBINATION MOLECULES, AND THEIR PRECURSORS, AND THE USE OF ALL OF THESE AS WEIGHT-LOSS AGENTS

2003294487-Ballast water treatment system